Randomized trial of a depression management program in high utilizers of medical care

被引:275
作者
Katzelnick, DJ
Simon, GE
Pearson, SD
Manning, WG
Helstad, CP
Henk, HJ
Cole, SM
Lin, EHB
Taylor, LH
Kobak, KA
机构
[1] Dean Fdn Hlth Res & Educ, Middleton, WI 53562 USA
[2] Harvard Pilgrim Hlth Care, Dept Ambulatory Care & Prevent, Boston, MA USA
[3] Harvard Med Sch, Boston, MA USA
[4] Grp Hlth Cooperat Puget Sound, Ctr Hlth Studies, Seattle, WA 98101 USA
[5] Univ Chicago, Dept Hlth Studies, Chicago, IL 60637 USA
关键词
D O I
10.1001/archfami.9.4.345
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: High utilizers of nonpsychiatric health care services have disproportionally high rates of undiagnosed or undertreated depression. Objective: To determine the impact of offering a systematic primary care-based depression treatment program to depressed "high utilizers" not in active treatment. Design: Randomized clinical trial. Setting: One hundred sixty-three primary care practices in 3 health maintenance organizations located in different geographic regions of the United States. Patients: A group of 1465 health maintenance organization members were identified as depressed high utilizers using a 2-stage telephone screening process. Eligibility criteria were met by 410 patients and 407 agreed to enroll: 218 in the depression management program (DMP) practices and 189 in the usual care (UC) group. Intervention: The DMP included patient education materials, physician education programs, telephone-based treatment coordination, and antidepressant pharmacotherapy initiated and managed by patients' primary care physicians. Main Outcome Measures: Depression severity was measured using the Hamilton Depression Rating Scale (Ham-D) and functional status using the Medical Outcomes Study 20-item short form (SF-20) subscales. Outpatient visit and hospitalization rates were measured using the health plan's encounter data. Results: Based on an intent-to-treat analysis, at least 3 antidepressant prescriptions were filled in the first 6 months by 151 (69.3%) of 218 of DMP patients vs 35 (18.5%) of 189 in UC (P<.001). Improvements in Ham-D scores were significantly greater in the intervention group at 6 weeks (P =.04), 3 months (P=.02), 6 months (P<.001), and 12 months (P<.001). At 12 months, DMP intervention patients were more improved than UC patients on the mental health, social functioning, and general health perceptions scales of the SF-20 (P<.05 for all). Conclusion: In depressed high utilizers not already in active treatment, a systematic primary care-based treatment program can substantially increase adequate antidepressant treatment, decrease depression severity, and improve general health status compared with usual care.
引用
收藏
页码:345 / 351
页数:7
相关论文
共 51 条
  • [1] *AM PSYCH ASS, 1993, AM J PSYCHIAT S, V150, pS1
  • [2] BECK AT, 1985, ARCH GEN PSYCHIAT, V42, P142
  • [3] Brown C, 1996, AM J PSYCHIAT, V153, P1293
  • [4] Brown R L, 1995, Wis Med J, V94, P135
  • [5] IMPROVING TREATMENT OF LATE-LIFE DEPRESSION IN PRIMARY-CARE - A RANDOMIZED CLINICAL-TRIAL
    CALLAHAN, CM
    HENDRIE, HC
    DITTUS, RS
    BRATER, DC
    HUI, SL
    TIERNEY, WM
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1994, 42 (08) : 839 - 846
  • [6] Fluvoxamine maleate in the treatment of depression: A single-center, double-blind, placebo-controlled comparison with imipramine in outpatients
    Claghorn, JL
    Earl, CQ
    Walczak, DD
    Stoner, KA
    Wong, LF
    Kanter, D
    Houser, VP
    [J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1996, 16 (02) : 113 - 120
  • [7] Treating depressed primary care patients improves their physical, mental, and social functioning
    Coulehan, JL
    Schulberg, HC
    Block, MR
    Madonia, MJ
    Rodriguez, E
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1997, 157 (10) : 1113 - 1120
  • [8] 12 MONTH OUTCOME OF DEPRESSION IN GENERAL-PRACTICE - DOES DETECTION OR DISCLOSURE MAKE A DIFFERENCE
    DOWRICK, C
    BUCHAN, I
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 1995, 311 (7015): : 1274 - 1276
  • [9] ELKIN I, 1989, ARCH GEN PSYCHIAT, V46, P971
  • [10] SERTRALINE SAFETY AND EFFICACY IN MAJOR DEPRESSION - A DOUBLE-BLIND FIXED-DOSE COMPARISON WITH PLACEBO
    FABRE, LF
    ABUZZAHAB, FS
    AMIN, M
    CLAGHORN, JL
    MENDELS, J
    PETRIE, WM
    DUBE, S
    SMALL, JG
    [J]. BIOLOGICAL PSYCHIATRY, 1995, 38 (09) : 592 - 602